The period prevalence and characteristics of rare disorders in patients with epilepsy at 2 epilepsy centers, Germany

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00020928

Enrollment

600

Registered

2020-03-05

Start date

2020-04-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G40.2

Interventions

Group 1: Number of epilepsy patients with rare diseases who are in the Epilepsy centers Kork and Bethel found in 2019 will be shown.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Confirmed diagnosis of epilepsy 2. Residence in the epilepsy center Kork or inpatient or outpatient treatment in the epilepsy center Kork and Bethel 3. In the period between January 1, 2019 and December 31, 2019

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
To demonstrate the prevalence of rare diseases related with epilepsy in the two epilepsy centers Kork and Bethel in 2019.	—

Secondary

Measure	Time frame
Seizure frequency, seizure types, dosage of anticonvulsants and number of comorbidity	—

Countries

Germany

Contacts

Public ContactTassanai Intravooth

Epilepsiezentrum Kork

tintravooth@epilepsiezentrum.de00497851842272

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026